Garry Fenton
- Organic Chemistry top 5%
- Molecular Biology
- Pharmacology top 10%
- Biotechnology top 10%
- Biochemistry top 10%
- Co-authors
- David W. KnightFrank BennettSteven D. BullAndrew W. MulvaneyAndrew D. SmithStephen G. DaviesDuncan ShawJessica Karlsson
- Topics
- Microbial Natural Products and Biosynthesis (5 papers)Asymmetric Synthesis and Catalysis (5 papers)Synthesis and Catalytic Reactions (4 papers)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
Garry Fenton
21 papers receiving 476 citations
Peers
Comparison fields: 5 of 61
- Organic Chemistry 378
- Molecular Biology 192
- Pharmacology 95
- Biotechnology 69
- Biochemistry 45
Countries citing papers authored by Garry Fenton
This map shows the geographic impact of Garry Fenton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garry Fenton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garry Fenton more than expected).
Fields of papers citing papers by Garry Fenton
This network shows the impact of papers produced by Garry Fenton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garry Fenton. The network helps show where Garry Fenton may publish in the future.
Co-authorship network of co-authors of Garry Fenton
This figure shows the co-authorship network connecting the top 25 collaborators of Garry Fenton. A scholar is included among the top collaborators of Garry Fenton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Garry Fenton. Garry Fenton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 15 | |
| 2 | 75 | |
| 3 | 49 | |
| 4 | 6 | |
| 5 | 8 | |
| 6 | 93 | |
| 7 | 6 | |
| 8 | 3 | |
| 9 | 1 | |
| 10 | 14 | |
| 11 | 8 | |
| 12 | 22 | |
| 13 | 10 | |
| 14 | 36 | |
| 15 | 26 | |
| 16 | 15 | |
| 17 | 52 | |
| 18 | 19 | |
| 19 | 13 | |
| 20 | 13 |
About Garry Fenton
Garry Fenton is a scholar working on Biotechnology, Organic Chemistry and Pharmacology, having authored 21 papers that have together received 512 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (5 papers), Asymmetric Synthesis and Catalysis (5 papers) and Synthesis and Catalytic Reactions (4 papers). The work is most often cited by research in Organic Chemistry (378 citations), Biotechnology (69 citations) and Biochemistry (45 citations). Garry Fenton has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include David W. Knight, Frank Bennett, Steven D. Bull, Andrew W. Mulvaney, Andrew D. Smith, Stephen G. Davies, Duncan Shaw, David W. Knight, Jessica Karlsson and Nigel Vicker. Their work appears in journals such as Chemical Communications, Journal of Medicinal Chemistry and Tetrahedron.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.